ULTRAVIOLET-VISIBLE REFERENCE SPECTRA

The ultraviolet-visible reference spectra presented here were obtained by the use of double- beam spectrophotometers with sample solutions prepared as specified in the individual monographs. The horizontal axis indicates the wavelength (nm) and the vertical axis indi- cates the absorbance. JP XVII Ultraviolet-visible Reference Spectra 22252225 Acebutolol Hydrochloride

Acemetacin

Acetohexamide 1

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22262226 Ultraviolet-visible Reference Spectra JP XVII Acetohexamide 2

Aciclovir

Aclarubicin Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22272227 Acrinol Hydrate

Actinomycin D

Adrenaline

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22282228 Ultraviolet-visible Reference Spectra JP XVII Afloqualone

Alimemazine Tartrate

Allopurinol

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22292229 Alminoprofen

Alprazolam

Alprenolol Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22302230 Ultraviolet-visible Reference Spectra JP XVII Alprostadil

Alprostadil Alfadex

Ambenonium Chloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22312231 Amiodarone Hydrochloride

Amitriptyline Hydrochloride

Amlexanox

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22322232 Ultraviolet-visible Reference Spectra JP XVII Amlodipine Besilate

Amosulalol Hydrochloride

Amoxapine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22332233 Amphotericin B

Ampiroxicam

Aprindine Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22342234 Ultraviolet-visible Reference Spectra JP XVII Argatroban Hydrate

Arotinolol Hydrochloride

Aspoxicillin Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22352235 Atenolol

Atorvastatin Calcium Hydrate

Azathioprine

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22362236 Ultraviolet-visible Reference Spectra JP XVII Azelastine Hydrochloride

Azelnidipine

Aztreonam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22372237 Bacampicillin Hydrochloride

Baclofen

Bamethan Sulfate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22382238 Ultraviolet-visible Reference Spectra JP XVII Benidipine Hydrochloride

Benserazide Hydrochloride

Benzalkonium Chloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22392239 Benzbromarone

Benzethonium Chloride

Benzylpenicillin Benzathine Hydrate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22402240 Ultraviolet-visible Reference Spectra JP XVII Benzylpenicillin Potassium

Bepotastine Besilate

Beraprost Sodium

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22412241 Berberine Chloride Hydrate

Berberine Tannate

Betahistine Mesilate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22422242 Ultraviolet-visible Reference Spectra JP XVII Betamethasone

Betamethasone Dipropionate

Betamipron

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22432243 Betaxolol Hydrochloride

Bezafibrate

Bifonazole

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22442244 Ultraviolet-visible Reference Spectra JP XVII Biperiden Hydrochloride

Bisacodyl

Bisoprolol Fumarate

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22452245 Bleomycin Hydrochloride

Bleomycin Sulfate

Bromazepam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22462246 Ultraviolet-visible Reference Spectra JP XVII Bromhexine Hydrochloride

Bromocriptine Mesilate

Brotizolam

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22472247 Bucumolol Hydrochloride

Bufetolol Hydrochloride

Buformin Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22482248 Ultraviolet-visible Reference Spectra JP XVII Bumetanide

Bupivacaine Hydrochloride Hydrate

Bupranolol Hydrochloride

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) JP XVII Ultraviolet-visible Reference Spectra 22492249 Buprenorphine Hydrochloride

Butenafine Hydrochloride

Butropium Bromide 1

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.) 22502250 Ultraviolet-visible Reference Spectra JP XVII Butropium Bromide 2

Cadralazine

Calcitonin Salmon

The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs, General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)